RB

Russell Basser

Medical Developments International Limited | Non-Executive Director
Dr Basser is a former corporate executive with over 30 years of international medical and biopharmaceutical experience, including 21 years at CSL. He has substantial expertise in international drug and vaccine development, having held multiple senior executive roles at CSL, including Senior Vice President (SVP) of Research and Development at CSL Seqirus; Chief Medical Officer at CSL Limited/CSL Behring; and SVP of Global Clinical Research and Development at CSL Behring/CSL Limited. During his time at CSL, he was responsible for globalising CSLs Clinical Research and Development group and for conception and execution of CSLs clinical trial strategies across a broad range of therapeutic areas from Phase 1 to commercialisation. He was a founding member of CSL Seqirus executive leadership team in 2015 as SVP of Research and Development until his retirement in April 2022.

Companies and Roles

Company
Title
Tenure
Since
MVP
MVP
Medical Developments International Limited
  • Non-Executive Director
2yrs, 10mthAug 2023
SPL
SPL
Starpharma Holdings Limited
  • Non-Executive Director
3yrs, 4mthFeb 2023

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
MVP
MVP
Medical Developments International Limited
30/10/2555,873N/AN/AN/A
SPL
SPL
Starpharma Holdings Limited
26/08/25271,428N/AN/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
MVP
MVP
Medical Developments International Limited
30/10/25
Buy
40,000$0.706$28,227On-market trade
SPL
SPL
Starpharma Holdings Limited
13/09/24
Buy
200,000$0.093$18,600On-market trade
MVP
MVP
Medical Developments International Limited
06/08/24
Buy
2,160$0.380$820As advised by the company
SPL
SPL
Starpharma Holdings Limited
12/04/24
Buy
71,428$0.140$10,002On-market trade
MVP
MVP
Medical Developments International Limited
03/04/24
Buy
15,873$0.615$9,761On-market trade